1. National Institute for Allergy and Infectious Diseases (NIAID, NIH): Online HIV Drug Resistance Database (PI: Robert W. Shafer, MD, 1R01AI68581-01A1), 04/01/06 - 3/31/11

2. National Institute for Allergy and Infectious Diseases (NIAID, NIH) supplement to the grant Identification of Multidrug-Resistant HIV-1 Isolates (PI: Robert W. Shafer, MD, AI46148-01): Supplement provided 1999-2005.

3. NIH/NIGMS Program Project on AIDS Structural Biology Program Project: Targeting Ensembles of Drug Resistant Protease Variants (PI: Celia Schiffer, PhD, University of Massachusetts): 2002-2007

4. University-wide AIDS Research Program (CR03-ST-524). Community collaborative award: Optimizing Clinical HIV Genotypic Resistance Interpretation: Principal Investigators: Robert W. Shafer, MD and W. Jeffrey Fessel MD (Kaiser Permanente Medical Care Program): 2004-2005

5. Stanford University Bio-X Interdisciplinary Initiative: HIV Gene Sequence Analysis for Drug Resistance Studies: A Pharmacogenetic Challenge Principal Investigators: Robert W. Shafer, MD and Daphne Koller, Ph.D. (Computer Science): 2000-2002

Abbott Laboratories (2000, 2002, 2004)
Agouron / Pfizer (1998, 2000)
Boehringer-Ingelheim (2002, 2004)
Bristol-Myers Squibb (2001, 2003, 2004, 2006)
Dupont Pharmaceuticals (2001)
Gilead Sciences (1998, 2001, 2004, 2006)
GlaxoSmithKline (1999, 2000, 2002, 2003, 2006)
Hoffman La Roche (1999, 2002, 2003, 2004, 2005, 2006)
Merck Pharmaceuticals (1998, 2000)
Triangle Pharmaceuticals (2002)

Applied Biosystems, Inc (1998, 2000, 2001)
Celera (2003, 2005 - 2007)
Hoffman La Roche (1999, 2003, 2004)
Visible Genetics (1999)

Laboratory Corporation of America (2003)
Nichols Institute (1999)
Specialty Laboratories (2000)
SRA Life Sciences (2000)

Virology Networks (1999, 2004)
Academy of Continuing Education Programs (ACEP) (2000)

J.M. Kaplan Foundation (2000)